They induced a significant increase in liver relative weight and serum levels of cancer markers (AFP and GGT) and liver enzymes (ALT, AST, and ALP), as well as intensive immunostaining for the HCC marker GST-P, and increased number and area of tumor AHF as compared to HCC rats injected by PBS. This evidence concerns the gene GSTP1 and hepatocellular carcinoma.